5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one

C110H154N10O9 — CID 160592216

IUPAC5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one
SMILESCC(C)(C)C(=O)N1CCc2ccccc2C1.CC(C)(C)c1ccc2c(c1)C(=O)NC2.CC(C)(C)c1ccc2c(c1)CC(=O)C2.CC(C)(C)c1ccc2c(c1)CCC(=O)N2.CC(C)(C)c1ccc2c(c1)CNC2=O.CC(C)(C)c1cnn(CCN2CCOCC2)c1.CN1CCOc2cc(C(C)(C)C)ccc21.Cn1ccc(C(C)(C)C)cc1=O.Cn1ccc(C(C)(C)C)cc1=O
InChIInChI=1S/C14H19NO.C13H23N3O.C13H19NO.C13H17NO.C13H16O.2C12H15NO.2C10H15NO/c1-14(2,3)13(16)15-9-8-11-6-4-5-7-12(11)10-15;1-13(2,3)12-10-14-16(11-12)5-4-15-6-8-17-9-7-15;1-13(2,3)10-5-6-11-12(9-10)15-8-7-14(11)4;1-13(2,3)10-5-6-11-9(8-10)4-7-12(15)14-11;1-13(2,3)11-5-4-9-7-12(14)8-10(9)6-11;1-12(2,3)9-4-5-10-8(6-9)7-13-11(10)14;1-12(2,3)9-5-4-8-7-13-11(14)10(8)6-9;2*1-10(2,3)8-5-6-11(4)9(12)7-8/h4-7H,8-10H2,1-3H3;10-11H,4-9H2,1-3H3;5-6,9H,7-8H2,1-4H3;5-6,8H,4,7H2,1-3H3,(H,14,15);4-6H,7-8H2,1-3H3;2*4-6H,7H2,1-3H3,(H,13,14);2*5-7H,1-4H3
InChIKeyRDEHJDKOCLVLIN-UHFFFAOYSA-N
MW1760.50 g/mol
LogP20.28
Rot. Bonds3

About 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one

5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one (PubChem CID 160592216) has the molecular formula C110H154N10O9 and a molecular weight of 1760.50 g/mol. Its IUPAC name is 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one.

Molecular Properties

Compound Name5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one
PubChem CID160592216
Molecular FormulaC110H154N10O9
Molecular Weight1760.50 g/mol
Exact Mass1759.19
IUPAC Name5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one
SMILESCC(C)(C)C(=O)N1CCc2ccccc2C1.CC(C)(C)c1ccc2c(c1)C(=O)NC2.CC(C)(C)c1ccc2c(c1)CC(=O)C2.CC(C)(C)c1ccc2c(c1)CCC(=O)N2.CC(C)(C)c1ccc2c(c1)CNC2=O.CC(C)(C)c1cnn(CCN2CCOCC2)c1.CN1CCOc2cc(C(C)(C)C)ccc21.Cn1ccc(C(C)(C)C)cc1=O.Cn1ccc(C(C)(C)C)cc1=O
InChIInChI=1S/C14H19NO.C13H23N3O.C13H19NO.C13H17NO.C13H16O.2C12H15NO.2C10H15NO/c1-14(2,3)13(16)15-9-8-11-6-4-5-7-12(11)10-15;1-13(2,3)12-10-14-16(11-12)5-4-15-6-8-17-9-7-15;1-13(2,3)10-5-6-11-12(9-10)15-8-7-14(11)4;1-13(2,3)10-5-6-11-9(8-10)4-7-12(15)14-11;1-13(2,3)11-5-4-9-7-12(14)8-10(9)6-11;1-12(2,3)9-4-5-10-8(6-9)7-13-11(10)14;1-12(2,3)9-5-4-8-7-13-11(14)10(8)6-9;2*1-10(2,3)8-5-6-11(4)9(12)7-8/h4-7H,8-10H2,1-3H3;10-11H,4-9H2,1-3H3;5-6,9H,7-8H2,1-4H3;5-6,8H,4,7H2,1-3H3,(H,14,15);4-6H,7-8H2,1-3H3;2*4-6H,7H2,1-3H3,(H,13,14);2*5-7H,1-4H3
InChIKeyRDEHJDKOCLVLIN-UHFFFAOYSA-N
XLogP20.28
TPSA211.44 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds3
Heavy Atoms129
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001760.50
LogP ≤ 520.28
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Analyze 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one?
The IUPAC name of 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one (CID 160592216) is 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one.
What is the SMILES notation for 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one?
The canonical SMILES for 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one is CC(C)(C)C(=O)N1CCc2ccccc2C1.CC(C)(C)c1ccc2c(c1)C(=O)NC2.CC(C)(C)c1ccc2c(c1)CC(=O)C2.CC(C)(C)c1ccc2c(c1)CCC(=O)N2.CC(C)(C)c1ccc2c(c1)CNC2=O.CC(C)(C)c1cnn(CCN2CCOCC2)c1.CN1CCOc2cc(C(C)(C)C)ccc21.Cn1ccc(C(C)(C)C)cc1=O.Cn1ccc(C(C)(C)C)cc1=O.
What is the InChIKey of 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one?
The InChIKey is RDEHJDKOCLVLIN-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H19NO.C13H23N3O.C13H19NO.C13H17NO.C13H16O.2C12H15NO.2C10H15NO/c1-14(2,3)13(16)15-9-8-11-6-4-5-7-12(11)10-15;1-13(2,3)12-10-14-16(11-12)5-4-15-6-8-17-9-7-15;1-13(2,3)10-5-6-11-12(9-10)15-8-7-14(11)4;1-13(2,3)10-5-6-11-9(8-10)4-7-12(15)14-11;1-13(2,3)11-5-4-9-7-12(14)8-10(9)6-11;1-12(2,3)9-4-5-10-8(6-9)7-13-11(10)14;1-12(2,3)9-5-4-8-7-13-11(14)10(8)6-9;2*1-10(2,3)8-5-6-11(4)9(12)7-8/h4-7H,8-10H2,1-3H3;10-11H,4-9H2,1-3H3;5-6,9H,7-8H2,1-4H3;5-6,8H,4,7H2,1-3H3,(H,14,15);4-6H,7-8H2,1-3H3;2*4-6H,7H2,1-3H3,(H,13,14);2*5-7H,1-4H3.
What are the key properties of 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one?
5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one has a molecular weight of 1760.50 g/mol, XLogP of 20.28, 3 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 5-tert-butyl-1,3-dihydroinden-2-one;5-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-2,3-dihydroisoindol-1-one;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-4-methyl-2,3-dihydro-1,4-benzoxazine;bis(4-tert-butyl-1-methylpyridin-2-one);4-[2-(4-tert-butylpyrazol-1-yl)ethyl]morpholine;1-(3,4-dihydro-1H-isoquinolin-2-yl)-2,2-dimethylpropan-1-one is sourced from PubChem (CID 160592216), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).